Latham & Watkins represented VillageMD in the transaction, Cleary Gottlieb and McDermott Will & Emery represented Summit Health-CityMD, while Wachtell, Lipton, Rosen & Katz served as legal...
VillageMD’s $8.9 Billion Acquisition of Summit Health-CityMD
Ouster’s Merger With Velodyne
Barclays served as financial advisor and Latham & Watkins served as legal advisor to Ouster. BofA Securities, Inc. served as financial advisor and Skadden, Arps, Slate,...
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
NextGen Healthcare’s $230 Million Convertible Senior Notes Offering
Latham & Watkins represented NextGen Healthcare, while Davis Polk advised J.P. Morgan Securities LLC, the representative of the initial purchasers in the offering. NextGen Healthcare, Inc....
JKN Global Media Public Company Limited’s Acquisition of The Miss Universe Organization
Latham & Watkins LLP represented IMG in the transaction. IMG, an Endeavor company and global leader in events, media, sports and fashion, has announced that it has...
Portland General Electric Company’s $434 Million Common Stock Offering
Latham & Watkins represented Portland General Electric Company in the offering, while Davis Polk acted as counsel to the representatives of the underwriters. Portland General Electric Company...
Cordis’ Acquisition of MedAlliance
Latham & Watkins represented MedAlliance in the transaction. Swiss-based medical technology company MedAlliance announced it has entered into an agreement with Cordis for an acquisition which includes...
Atlantic Park and GIC’s €550 Million investment in Cheplapharm
Latham & Watkins has advised CHEPLAPHARM AG on the deal. CHEPLAPHARM AG (CHEPLAPHARM), a leading international platform for well-established branded medicines, announced its agreement for a...
Eric Goupil, GIC, IK Partners, Keensight and Parquest’s Acquisition of Unither Pharmaceuticals
Kirkland advised GIC, while Latham & Watkins advised Ardian on the deal. Arsene, Goodwin and Deloitte Société d’Avocats advised IK Partners, GIC, Keensight Capital and Parquest....
Orbital Therapeutics’ Partnership With Beam Therapeutics
Latham & Watkins advised Orbital Therapeutics on the deal. Orbital Therapeutics, which aims to enhance global health by unleashing the full potential of RNA medicine, announced...
Diamondback Energy’s $1.1 Billion Notes Offering
Akin Gump advised Diamondback Energy on the deal, while Latham & Watkins represented the underwriters. Independent oil and natural gas company Diamondback Energy, Inc. (NASDAQ: FANG) announced its...
Vaxcyte’s $690 Million Public Offering
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...